THERESE BARTHOLOMEW BEVERS

Concepts (337)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Early Detection of Cancer
17
2023
1338
2.770
Why?
Breast Neoplasms
65
2024
16183
2.630
Why?
Mass Screening
12
2024
1545
2.510
Why?
Selective Estrogen Receptor Modulators
10
2018
128
1.990
Why?
Mammography
18
2024
1052
1.510
Why?
Raloxifene Hydrochloride
8
2015
46
1.210
Why?
Aromatase Inhibitors
4
2022
311
1.200
Why?
Risk Reduction Behavior
5
2017
209
1.140
Why?
Carcinoma, Lobular
5
2023
616
0.870
Why?
Uterine Cervical Dysplasia
4
2023
209
0.860
Why?
Patient Participation
6
2020
453
0.830
Why?
Tamoxifen
12
2022
875
0.810
Why?
Hyperplasia
7
2023
557
0.810
Why?
Medical Oncology
3
2023
1463
0.800
Why?
Breast Carcinoma In Situ
2
2020
17
0.780
Why?
Breast Self-Examination
2
2012
17
0.770
Why?
Breast
8
2021
1366
0.750
Why?
Decision Making
7
2018
1249
0.680
Why?
Precancerous Conditions
4
2023
1033
0.660
Why?
Smokers
1
2020
154
0.630
Why?
Squamous Intraepithelial Lesions of the Cervix
1
2017
11
0.580
Why?
Decision Support Techniques
3
2020
601
0.540
Why?
Exercise
4
2021
1206
0.540
Why?
Female
80
2024
148486
0.530
Why?
Health Knowledge, Attitudes, Practice
4
2022
1231
0.510
Why?
Risk Assessment
15
2024
6752
0.500
Why?
Papillomavirus Infections
3
2023
999
0.500
Why?
Uterine Cervical Neoplasms
5
2023
1900
0.480
Why?
Carcinoma in Situ
2
2015
488
0.470
Why?
Middle Aged
55
2024
90030
0.450
Why?
Patient-Centered Care
1
2016
318
0.440
Why?
Awareness
2
2012
114
0.430
Why?
Breast Density
3
2024
20
0.420
Why?
Tomography, X-Ray Computed
3
2020
7779
0.420
Why?
Insurance Coverage
1
2014
274
0.400
Why?
Humans
83
2024
270033
0.390
Why?
Practice Guidelines as Topic
4
2019
2388
0.380
Why?
Lung Neoplasms
4
2020
12019
0.360
Why?
High-Intensity Interval Training
2
2021
10
0.360
Why?
Carcinoma, Intraductal, Noninfiltrating
4
2023
690
0.360
Why?
Breast Diseases
3
2020
200
0.360
Why?
Adult
40
2024
81689
0.340
Why?
Risk Factors
21
2023
17824
0.330
Why?
Medicare
1
2014
925
0.330
Why?
Dietary Supplements
2
2024
562
0.300
Why?
Vaginal Smears
4
2023
166
0.280
Why?
Ultrasonography, Mammary
6
2022
387
0.280
Why?
Aged
35
2024
73127
0.270
Why?
Age Factors
6
2018
5449
0.270
Why?
Overweight
2
2020
484
0.270
Why?
Algorithms
2
2016
3896
0.260
Why?
Health Literacy
2
2019
117
0.260
Why?
Patient Compliance
3
2019
676
0.250
Why?
Volatile Organic Compounds
1
2024
13
0.240
Why?
Carcinoma, Ductal, Breast
4
2019
1229
0.240
Why?
Cholecalciferol
1
2024
49
0.230
Why?
Breath Tests
1
2024
192
0.230
Why?
Counseling
4
2023
381
0.230
Why?
Cardiorespiratory Fitness
2
2021
20
0.230
Why?
Quality of Life
2
2016
4772
0.230
Why?
Perception
4
2022
349
0.220
Why?
Neoplasms
5
2019
15902
0.220
Why?
Biopsy, Large-Core Needle
4
2023
139
0.220
Why?
United States
7
2020
15776
0.220
Why?
Catechin
2
2014
34
0.220
Why?
Health Promotion
1
2007
510
0.220
Why?
Premenopause
2
2024
138
0.220
Why?
Family Practice
1
2023
131
0.210
Why?
Neoplasm Recurrence, Local
5
2020
10382
0.210
Why?
Nipple Discharge
1
2022
8
0.210
Why?
Cancer Survivors
2
2020
744
0.210
Why?
Anticarcinogenic Agents
2
2001
368
0.200
Why?
Societies, Medical
2
2018
1318
0.200
Why?
Health Personnel
3
2023
649
0.200
Why?
Point-of-Care Systems
1
2024
212
0.200
Why?
Medical Overuse
2
2018
51
0.190
Why?
Risk
6
2021
1937
0.190
Why?
Vitamin D
2
2024
261
0.190
Why?
Primary Prevention
2
2015
233
0.190
Why?
Mastectomy
4
2022
1553
0.190
Why?
Celecoxib
1
2020
198
0.170
Why?
Resistance Training
1
2019
39
0.160
Why?
Postmenopause
5
2019
377
0.160
Why?
Comprehension
1
2019
103
0.160
Why?
Papanicolaou Test
2
2017
116
0.160
Why?
Device Removal
1
2021
338
0.160
Why?
Randomized Controlled Trials as Topic
4
2018
2646
0.160
Why?
Obesity
3
2020
2901
0.160
Why?
Patient Education as Topic
2
2021
744
0.160
Why?
Stakeholder Participation
1
2018
42
0.150
Why?
CA-125 Antigen
2
2024
228
0.150
Why?
Neoplasms, Radiation-Induced
1
2020
402
0.150
Why?
Health Behavior
2
2015
600
0.150
Why?
False Positive Reactions
1
2018
372
0.150
Why?
Antineoplastic Agents
4
2015
14615
0.150
Why?
Health Communication
1
2018
36
0.150
Why?
Atypical Squamous Cells of the Cervix
1
2017
3
0.150
Why?
Health Plan Implementation
1
2018
83
0.150
Why?
Human Papillomavirus DNA Tests
1
2017
16
0.150
Why?
Incidence
7
2018
5806
0.140
Why?
Ultrasonography
4
2024
1928
0.140
Why?
Receptors, Estrogen
4
2016
2158
0.140
Why?
Li-Fraumeni Syndrome
1
2018
166
0.140
Why?
Professional-Patient Relations
1
2017
114
0.140
Why?
Genital Neoplasms, Female
1
2023
788
0.140
Why?
Motivation
1
2020
516
0.140
Why?
Endometrial Neoplasms
3
2024
1388
0.140
Why?
Breast Implants
1
2021
375
0.140
Why?
Magnetic Resonance Imaging
7
2023
7892
0.130
Why?
Patient Preference
1
2018
228
0.130
Why?
Feasibility Studies
3
2020
2358
0.130
Why?
Logistic Models
7
2021
3438
0.130
Why?
Follow-Up Studies
6
2019
15172
0.130
Why?
Program Evaluation
1
2018
601
0.120
Why?
Biomarkers
2
2019
5046
0.120
Why?
Information Dissemination
1
2018
266
0.120
Why?
Aged, 80 and over
8
2020
30923
0.120
Why?
Clinical Decision-Making
1
2018
530
0.120
Why?
Delivery of Health Care, Integrated
1
2016
165
0.120
Why?
Health Education
1
2017
303
0.120
Why?
Retrospective Studies
12
2023
39736
0.120
Why?
Surveys and Questionnaires
5
2020
5906
0.120
Why?
Biopsy
3
2018
3384
0.120
Why?
North America
1
2015
337
0.120
Why?
Androstadienes
1
2015
172
0.120
Why?
Tea
1
2014
46
0.120
Why?
Computer Simulation
1
2019
1570
0.120
Why?
Erotica
1
2013
11
0.120
Why?
Internet
2
2017
689
0.110
Why?
Mammaplasty
1
2021
714
0.110
Why?
Genetic Predisposition to Disease
3
2018
5773
0.110
Why?
Cognition
2
2010
968
0.110
Why?
Libido
1
2013
37
0.110
Why?
Papilloma
1
2013
86
0.110
Why?
Patient Care Team
2
2016
822
0.110
Why?
Activities of Daily Living
1
2016
553
0.110
Why?
Evidence-Based Medicine
1
2018
1032
0.110
Why?
Ovarian Neoplasms
2
2024
4785
0.110
Why?
Adenocarcinoma, Mucinous
1
2017
440
0.110
Why?
Sexual Dysfunctions, Psychological
1
2013
71
0.110
Why?
Patient Acceptance of Health Care
1
2018
599
0.110
Why?
Human papillomavirus 18
1
2012
42
0.110
Why?
Russia
1
2012
55
0.100
Why?
Predictive Value of Tests
5
2024
4944
0.100
Why?
Receptors, Progesterone
2
2016
1603
0.100
Why?
Neoplasm Grading
1
2017
1821
0.100
Why?
Biopsy, Fine-Needle
2
2020
687
0.100
Why?
Biomarkers, Tumor
6
2024
10695
0.100
Why?
Video Recording
1
2014
278
0.100
Why?
Plant Extracts
1
2014
225
0.100
Why?
Vaginal Neoplasms
1
2012
152
0.100
Why?
Life Style
1
2015
617
0.100
Why?
Biopsy, Needle
2
2012
1376
0.090
Why?
India
1
2012
312
0.090
Why?
Human papillomavirus 16
1
2012
255
0.090
Why?
China
1
2012
634
0.090
Why?
Intercellular Signaling Peptides and Proteins
1
2014
657
0.090
Why?
Triazoles
1
2015
628
0.090
Why?
Inflammatory Breast Neoplasms
1
2016
530
0.090
Why?
Estrogens, Conjugated (USP)
1
2010
34
0.090
Why?
Nitriles
1
2015
938
0.090
Why?
Minority Health
1
2009
16
0.090
Why?
Databases, Factual
1
2017
2231
0.090
Why?
Radiography
1
2014
1984
0.080
Why?
Insulin-Like Growth Factor Binding Protein 3
2
2020
156
0.080
Why?
Radiation Dosage
1
2014
1042
0.080
Why?
Male
9
2020
127917
0.080
Why?
Neoplasms, Hormone-Dependent
1
2010
347
0.080
Why?
Neoplasms, Second Primary
1
2017
1387
0.080
Why?
Antineoplastic Agents, Hormonal
2
2005
841
0.080
Why?
Nomograms
1
2010
312
0.080
Why?
Prognosis
6
2019
22451
0.080
Why?
Pilot Projects
3
2020
2843
0.070
Why?
Decision Trees
1
2007
181
0.070
Why?
Double-Blind Method
4
2019
2586
0.070
Why?
Image-Guided Biopsy
2
2023
336
0.070
Why?
Insulin-Like Growth Factor I
2
2020
629
0.070
Why?
Tumor Suppressor Protein p53
2
2018
3653
0.070
Why?
Attitude to Health
1
2009
434
0.070
Why?
Practice Patterns, Physicians'
1
2015
1299
0.070
Why?
Genetic Testing
1
2015
1695
0.070
Why?
Time Factors
2
2018
12953
0.070
Why?
Estrogens
1
2010
808
0.070
Why?
Postoperative Complications
1
2021
5666
0.060
Why?
Alphapapillomavirus
1
2007
172
0.060
Why?
Treatment Outcome
4
2020
33691
0.060
Why?
Estrogen Receptor Modulators
1
2005
110
0.060
Why?
Survivors
2
2013
1022
0.060
Why?
Smoking
1
2014
2548
0.060
Why?
Body Weight
2
2020
1306
0.060
Why?
Psychometrics
1
2009
969
0.060
Why?
Brain
2
2018
4210
0.060
Why?
Case-Control Studies
5
2017
6204
0.060
Why?
Thyroid Hormones
1
2005
111
0.060
Why?
Qualitative Research
2
2018
635
0.060
Why?
Lysophospholipids
1
2004
148
0.060
Why?
Odds Ratio
3
2017
2296
0.050
Why?
Sexual Behavior
1
2005
313
0.050
Why?
Hypothyroidism
1
2005
207
0.050
Why?
Prospective Studies
6
2020
13378
0.050
Why?
Premedication
1
2002
133
0.050
Why?
Dissent and Disputes
1
2022
40
0.050
Why?
Ki-67 Antigen
2
2020
675
0.050
Why?
Medical Device Recalls
1
2021
5
0.050
Why?
Models, Statistical
1
2007
1185
0.050
Why?
Silicone Gels
1
2021
19
0.050
Why?
Ambulatory Care Facilities
1
2023
294
0.050
Why?
Surface Properties
1
2021
188
0.050
Why?
Adaptation, Psychological
1
2005
787
0.050
Why?
Carcinoma
1
2012
2607
0.050
Why?
Insulin-Like Growth Factor Binding Protein 1
1
2020
30
0.050
Why?
Equipment Failure
1
2021
191
0.040
Why?
Papillomaviridae
1
2023
636
0.040
Why?
Texas
3
2019
6430
0.040
Why?
Promoter Regions, Genetic
1
2007
3210
0.040
Why?
BRCA2 Protein
1
2022
379
0.040
Why?
Neoplasm Staging
5
2016
13996
0.040
Why?
Body Mass Index
2
2019
2238
0.040
Why?
Histones
1
2007
1512
0.040
Why?
Audiovisual Aids
1
2019
39
0.040
Why?
Blood Glucose Self-Monitoring
1
2020
118
0.040
Why?
DNA Damage
1
2007
1981
0.040
Why?
Truth Disclosure
1
2021
178
0.040
Why?
Triage
1
2021
256
0.040
Why?
Radiotherapy
1
2006
1858
0.040
Why?
BRCA1 Protein
1
2022
525
0.040
Why?
Genetic Variation
1
2007
2165
0.040
Why?
Dose-Response Relationship, Drug
2
2020
5061
0.040
Why?
Prosthesis Design
1
2021
653
0.040
Why?
Breast Implantation
1
2021
222
0.040
Why?
Confidence Intervals
2
2012
748
0.040
Why?
Pamphlets
1
2018
34
0.040
Why?
Exercise Therapy
1
2021
293
0.040
Why?
Tretinoin
1
2000
618
0.040
Why?
Asymptomatic Diseases
1
2018
103
0.040
Why?
Life Expectancy
1
2018
129
0.040
Why?
Sensitivity and Specificity
3
2019
5153
0.040
Why?
Organs at Risk
1
2020
558
0.040
Why?
Combined Modality Therapy
2
2006
9040
0.040
Why?
Whole Body Imaging
1
2018
120
0.040
Why?
Culture
1
2017
104
0.040
Why?
Thromboembolism
2
2010
150
0.040
Why?
Patient Outcome Assessment
1
2018
245
0.030
Why?
Lymphoma, Large-Cell, Anaplastic
1
2021
389
0.030
Why?
Observation
1
2016
52
0.030
Why?
Trust
1
2017
109
0.030
Why?
Anxiety
1
2023
1236
0.030
Why?
Probability
2
2010
883
0.030
Why?
Cataract
2
2010
236
0.030
Why?
Neuropsychological Tests
2
2010
1145
0.030
Why?
Disease Management
1
2021
1087
0.030
Why?
Blood Glucose
1
2020
1260
0.030
Why?
Informed Consent
1
2018
416
0.030
Why?
Heterozygote
1
2018
1055
0.030
Why?
Myocardial Ischemia
2
2010
400
0.030
Why?
Health Status
1
2018
630
0.030
Why?
Disease-Free Survival
1
2006
10258
0.030
Why?
Chemotherapy, Adjuvant
1
2002
3993
0.030
Why?
Breast Feeding
1
2016
246
0.030
Why?
Forecasting
1
2016
699
0.030
Why?
Adenocarcinoma
2
2010
7883
0.030
Why?
Registries
2
2016
2205
0.030
Why?
Hepatocyte Growth Factor
1
2014
155
0.030
Why?
Arousal
1
2013
128
0.030
Why?
Neoplasm Invasiveness
2
2012
4043
0.030
Why?
Placebos
1
2014
443
0.030
Why?
Fractures, Bone
2
2006
310
0.030
Why?
Germ-Line Mutation
1
2018
1101
0.030
Why?
Photomicrography
1
2012
23
0.030
Why?
Triglycerides
1
2014
610
0.020
Why?
Patient Safety
1
2016
612
0.020
Why?
Magnetic Resonance Imaging, Interventional
1
2012
106
0.020
Why?
Cholesterol
1
2014
658
0.020
Why?
Receptor, ErbB-2
2
2016
2650
0.020
Why?
Osteoporosis, Postmenopausal
1
2010
40
0.020
Why?
Emotions
1
2013
560
0.020
Why?
Radiography, Interventional
1
2012
311
0.020
Why?
Fractures, Spontaneous
1
2010
87
0.020
Why?
Principal Component Analysis
1
2009
224
0.020
Why?
Drug Utilization
1
2010
188
0.020
Why?
Maximum Tolerated Dose
1
2012
1320
0.020
Why?
Ultrasonography, Interventional
1
2012
424
0.020
Why?
Area Under Curve
1
2010
729
0.020
Why?
Models, Psychological
1
2009
178
0.020
Why?
Women's Health
1
2009
197
0.020
Why?
Young Adult
2
2018
22134
0.020
Why?
DNA Probes, HPV
1
2007
12
0.020
Why?
Least-Squares Analysis
1
2007
66
0.020
Why?
Vascular Endothelial Growth Factor A
1
2014
1577
0.020
Why?
Diagnosis, Differential
1
2016
4819
0.020
Why?
Research Design
2
2005
1569
0.020
Why?
Patient Selection
2
2005
2026
0.020
Why?
Carcinoma, Adenosquamous
1
2005
107
0.020
Why?
In Situ Hybridization
1
2007
1039
0.020
Why?
Triple Negative Breast Neoplasms
1
2016
1391
0.020
Why?
Thyroid Function Tests
1
2005
38
0.020
Why?
Chi-Square Distribution
1
2008
1309
0.020
Why?
DNA, Viral
1
2007
753
0.020
Why?
Uterus
1
2010
798
0.020
Why?
Bias
1
2005
214
0.020
Why?
Thyroxine
1
2005
114
0.020
Why?
Infant, Newborn
1
2018
8668
0.020
Why?
Genotype
1
2012
4249
0.010
Why?
Hydrolysis
1
2004
233
0.010
Why?
Carcinoma, Squamous Cell
2
2012
5585
0.010
Why?
Osteoporosis
1
2005
232
0.010
Why?
Age Distribution
1
2005
713
0.010
Why?
Cause of Death
1
2006
778
0.010
Why?
Reference Values
1
2005
1130
0.010
Why?
Pregnancy
1
2016
8107
0.010
Why?
Fenretinide
1
2002
100
0.010
Why?
Infant
1
2018
13946
0.010
Why?
Mutation
1
2022
15900
0.010
Why?
Hysterectomy
1
2005
651
0.010
Why?
Uterine Neoplasms
1
2006
576
0.010
Why?
Child, Preschool
1
2018
16987
0.010
Why?
Receptors, Retinoic Acid
1
2002
369
0.010
Why?
Alleles
1
2007
2590
0.010
Why?
Prodrugs
1
2002
226
0.010
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2002
16640
0.010
Why?
Thrombosis
1
2006
741
0.010
Why?
Cohort Studies
1
2012
9464
0.010
Why?
Proportional Hazards Models
1
2008
5099
0.010
Why?
Comorbidity
1
2005
2389
0.010
Why?
Neoplasm Metastasis
1
2008
5309
0.010
Why?
Multivariate Analysis
1
2005
4318
0.010
Why?
Stroke
1
2005
1057
0.010
Why?
Adolescent
1
2018
32647
0.010
Why?
DNA, Neoplasm
1
2002
1957
0.010
Why?
Disease Progression
1
2008
6840
0.010
Why?
Child
1
2018
30466
0.010
Why?
Signal Transduction
1
2014
12087
0.010
Why?
Polymorphism, Single Nucleotide
1
2007
4646
0.010
Why?
Severity of Illness Index
1
2005
4360
0.010
Why?
Survival Analysis
1
2005
9288
0.010
Why?
Neoplasm Proteins
1
2002
3343
0.010
Why?
Animals
1
2004
61714
0.000
Why?
BEVERS's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (337)
Explore
_
Co-Authors (87)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_